Breakout Ventures has successfully closed its $114 million Fund III, aimed at supporting early-stage startups that leverage artificial intelligence in scientific domains such as biology and chemistry.
The firm has already made initial investments in three companies and aims to back at least 20 startups with average investment sizes between $500,000 and $5 million. Lindy Fishburne, the managing director of Breakout Ventures, emphasized their focus on firms dedicated to "unlocking the complexity of science with AI," in an interview with TechCrunch.
Founded in 2016 as a spin-off from a grant initiative of the Thiel Foundation, Breakout Ventures has previously raised two funds: a $60 million Fund I in 2017 and a $112.5 million Fund II in 2021, both centered on scientific innovation.
"Our mission has always been to harness technology to tap into the potential of biology and chemistry, addressing significant unmet needs and fostering new market opportunities," Fishburne stated. The process of raising Fund III took approximately 18 months, with contributions from limited partners such as The Kraft Group, Pinegrove Venture Partners, and Cubed Capital.
Breakout Ventures seeks founders who may either be PhDs with the scientific expertise necessary for commercialization or industry professionals who possess a deep understanding of market needs. "We prioritize alignment--identifying the right individual to lead a specific venture is crucial," Fishburne added.
This significant funding initiative not only highlights the growing investment in AI-driven scientific innovation but also sets the stage for transformative advancements in various scientific fields, paving the way for future breakthroughs that could reshape industries.
